Bydureon
Drug timelines are a Plus or Pro feature.
16 regulatory and trial events tracked for Bydureon, covering 2012-08-17 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes